- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 317/26 - Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
Patent holdings for IPC class C07D 317/26
Total number of patents in this class: 60
10-year publication summary
8
|
2
|
6
|
5
|
3
|
2
|
3
|
2
|
4
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Syngenta Limited | 482 |
3 |
Ambrx, Inc. | 192 |
3 |
3m Innovative Properties Company | 17968 |
2 |
BASF SE | 20367 |
2 |
Merck Sharp & Dohme Corp. | 2218 |
2 |
Firmenich SA | 1667 |
2 |
Givaudan SA | 1819 |
2 |
M2I Development | 5 |
2 |
Reata Pharmaceuticals, Inc. | 122 |
2 |
Stichting voor de Technische Wetenschappen | 132 |
2 |
UMC Utrecht Holding B.V. | 201 |
2 |
Universiteit Utrecht Holding B.V. | 130 |
2 |
M2I Salin | 2 |
2 |
MSD R & D (China) Co. LTD. | 53 |
2 |
AstraZeneca AB | 2961 |
1 |
Syngenta Participations AG | 3039 |
1 |
Massachusetts Institute of Technology | 9903 |
1 |
Sumitomo Chemical Company, Limited | 8966 |
1 |
Agricultural Research Council | 23 |
1 |
Ardelyx, Inc. | 112 |
1 |
Other owners | 24 |